Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials. For some patients, injectables ...

Sign Up for Wine Spectator’s Free Email Newsletters and stay up-to-date with all things wine.